𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunogenetic analysis of the immune response to pneumococcal polysaccharide

✍ Scribed by Helen E. Baxendale; Zadie Davis; Harry N. White; Myfanwy B. Spellerberg; Freda K. Stevenson; David Goldblatt

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
154 KB
Volume
30
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody response to pneumococcal polysa
Antibody response to pneumococcal polysaccharide vaccine in Myasthenia gravis: Effect of therapeutic plasmapheresis
✍ Thomas J. Nasca; Robert R. Muder; Dian B. Thomas; Judith C. Schrecker; Frederick 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

## Abstract The removal of specific antibody in experimental animals has been reported to result in a subsequent increase in antibody to levels equal to (rebound) or exceeding those existing prior to removal (overshoot). Anecdotal reports suggest that rebound antibody synthesis after plasmapheresis

The immunological properties of haptens
The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyllysinesubstituted pneumococcal polysaccharide (SIII) and levan
✍ G. G. B. Klaus; J. H. Humphrey 📂 Article 📅 1974 🏛 John Wiley and Sons 🌐 English ⚖ 891 KB

## Abstract The antibody response to the hapten 2,4dinitrophenyl (DNP)lysine coupled to two thymus‐independent carrier molecules (pneumococcal polysaccharide SIII and levan) has been studied in mice. The characteristics of the anti‐hapten response are essentially similar to the response to the ca

Early life T cell responses to pneumococ
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy
✍ Håvard Jakobsen; Solveig Hannesdottir; Stefania P. Bjarnarson; Dominique Schulz; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

## Abstract Immunization with a tetanus‐protein (TT) pneumococcal polysaccharide (PPS) conjugate vaccine (Pnc1‐TT) induces protective immunity against lethal pneumococcal infections in neonatal and infant mice, but anti‐PPS IgG response and protective efficacy is lower than in adult mice. Here, we